Publications by authors named "Yuji Shibata"

Claim this Profile
E
Efficacy and safety of upfront radiotherapy with immune checkpoint inhibitors for brain metastasis in non-small cell lung cancer.
Yu Tanaka, Hiroki Izumi, Eri Sugiyama, Tetsuya Sakai, Yuji Shibata

Cancer Treat Res Commun· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of EGFR tyrosine kinase inhibitors in patients with non-small cell lung cancer with EGFR exon 19 insertions: clinical-genomic, preclinical analysis through LC-SCRUM-Asia (multi-institutional genomic screening registry).
Yuji Uehara, Hiroki Izumi, Ikei S Kobayashi, Shingo Matsumoto, Yukio Hosomi, Yuji Shibata

Lung Cancer· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Significance of a Prospective Large Genomic Screening for SCLC: The Genetic Classification and a Biomarker-Driven Phase 2 Trial of Gedatolisib.
Shigeki Umemura, Hibiki Udagawa, Takaya Ikeda, Haruyasu Murakami, Haruko Daga, Yuji Shibata

J Thorac Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A simplified scoring system for predicting treatment response in limited-stage small-cell lung cancer (EAST score).
Yu Ito, Yoshitaka Zenke, Tetsuya Sakai, Yuji Shibata, Hiroki Izumi

Future Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of immune checkpoint inhibitors plus platinum-based chemotherapy as 1st line treatment for patients with non-small cell lung cancer harboring HER2 mutations: Results from LC-SCRUM-Asia.
Yuki Kato, Hibiki Udagawa, Shingo Matsumoto, Hiroki Izumi, Yuichiro Ohe, Yuji Shibata

Lung Cancer· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes in patients with non-small cell lung cancer harboring EGFR Exon20 in-frame insertions in the near-loop and far-loop: Results from LC-SCRUM-Asia.
Masanobu Okahisa, Hibiki Udagawa, Shingo Matsumoto, Terufumi Kato, Hiroshi Yokouchi, Yuji Shibata

Lung Cancer· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LTK mutations responsible for resistance to lorlatinib in non-small cell lung cancer harboring CLIP1-LTK fusion.
Shunta Mori, Hiroki Izumi, Mitsugu Araki, Jie Liu, Yu Tanaka, Yuji Shibata

Commun Biol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of predominant subtype in pathological stage II-III lung adenocarcinoma with epidermal growth factor receptor mutation.
Shingo Kitagawa, Yoshitaka Zenke, Tetsuro Taki, Keiju Aokage, Tetsuya Sakai, Yuji Shibata

Lung Cancer· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HER4 and EGFR Activate Cell Signaling in NRG1 Fusion-Driven Cancers: Implications for HER2-HER3-specific Versus Pan-HER Targeting Strategies.
Hibiki Udagawa, Monique B Nilsson, Jacqulyne P Robichaux, Junqin He, Alissa Poteete, Yuji Shibata

J Thorac Oncol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinicogenomic Features and Targetable Mutations in NSCLCs Harboring BRAF Non-V600E Mutations: A Multi-Institutional Genomic Screening Study (LC-SCRUM-Asia).
Tetsuya Sakai, Shingo Matsumoto, Yasuto Ueda, Yuji Shibata, Takaya Ikeda

J Thorac Oncol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic impact and gene expression analysis of peri-tumoral alveolar macrophage in resected lung adenocarcinoma.
Yosuke Kagawa, Tokiko Nakai, Tetsuro Taki, Hiroko Hashimoto, Yu Tanaka, Yuji Shibata

Cancer Sci· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinicopathological significance of peritumoral alveolar macrophages in patients with resected early-stage lung squamous cell carcinoma.
Yu Tanaka, Tokiko Nakai, Ayako Suzuki, Yosuke Kagawa, Osamu Noritake, Yuji Shibata

Cancer Immunol Immunother· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Large-Scale Prospective Concordance Study of Plasma- and Tissue-Based Next-Generation Targeted Sequencing for Advanced Non-Small Cell Lung Cancer (LC-SCRUM-Liquid).
Akira Sugimoto, Shingo Matsumoto, Hibiki Udagawa, Ryo Itotani, Yuko Usui, Yuji Shibata

Clin Cancer Res· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Large-scale clinico-genomic profile of non-small cell lung cancer with KRAS G12C: Results from LC-SCRUM-Asia study.
Yutaro Tamiya, Shingo Matsumoto, Yoshitaka Zenke, Kiyotaka Yoh, Takaya Ikeda, Yuji Shibata

Lung Cancer· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of tertiary lymphoid structures on clinicopathological, genetic and gene expression characteristics in lung adenocarcinoma.
Yutaro Tamiya, Tokiko Nakai, Ayako Suzuki, Sachiyo Mimaki, Katsuya Tsuchihara, Yuji Shibata

Lung Cancer· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
VEGF-C/VEGFR-3 signalling in macrophages ameliorates acute lung injury.
Masahiro Yamashita, Miyuki Niisato, Yasushi Kawasaki, Sinem Karaman, Marius R Robciuc, Yuji Shibata

Eur Respir J· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decidualization of Stromal Cells Promotes Involvement of Mast Cells in Successful Human Pregnancy by Increasing Stem Cell Factor Expression.
Chiyuki Ueshima, Tatsuki R Kataoka, Mitsumasa Osakabe, Akihiko Sugimoto, Akihiko Ushirokawa, Yuji Shibata

Front Immunol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolites Produced by a New Strain BF1-13 Isolated from Deep Seawater of Izu-Akazawa Protect the Intestinal Epithelial Barrier from the Dysfunction Induced by Hydrogen Peroxide.
Xiaozhen Diao, Katsuhisa Yamada, Yuji Shibata, Chiaki Imada

Mar Drugs· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The CLIP1-LTK fusion is an oncogenic driver in non-small-cell lung cancer.
Hiroki Izumi, Shingo Matsumoto, Jie Liu, Kosuke Tanaka, Shunta Mori, Yuji Shibata

Nature· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-Cell Analyses Reveal Diverse Mechanisms of Resistance to EGFR Tyrosine Kinase Inhibitors in Lung Cancer.
Yukie Kashima, Daisuke Shibahara, Ayako Suzuki, Kyoko Muto, Ikei S Kobayashi, Yuji Shibata

Cancer Res· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overview of checkpoint inhibitor pneumonitis: incidence and associated risk factors.
Yuji Shibata, Shuji Murakami, Terufumi Kato

Expert Opin Drug Saf· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Comprehensive Genomic Analysis for Small Cell Lung Cancer].
Yuji Shibata, Hibiki Udagawa, Shingo Matsumoto, Koichi Goto

Gan To Kagaku Ryoho· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of variant frequency in SARS-CoV-2 infection-related genes utilizing lung cancer genomic database.
Yuji Shibata, Shingo Matsumoto, Kiyotaka Yoh, Koichi Goto

Lung Cancer· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety evaluation of durvalumab for the treatment of non-small-cell lung cancer.
Yuji Shibata, Shuji Murakami

Expert Opin Drug Saf· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility of IVIM parameters from diffusion-weighted imaging at 11.7T MRI for detecting ischemic changes in common carotid artery occlusion rats.
Shunrou Fujiwara, Yuki Mori, Daniela Martinez de la Mora, Yosuke Akamatsu, Kenji Yoshida, Yuji Shibata

Sci Rep· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis